ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Antibody Validation Article
Revised

Immunoblotting validation of research antibodies generated against HS1-associated protein X-1 in the human neutrophil model cell line PLB-985.

[version 2; peer review: 3 approved]
PUBLISHED 10 Aug 2015
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

This article is included in the Antibody Validations gateway.

Abstract

HS1-associated protein X-1 (Hax1) is a 35 kDa protein that is ubiquitously expressed. Hax1 is an anti-apoptotic protein with additional roles in cell motility, and autosomal recessive loss of Hax1 results in Kostmann syndrome, a form of severe congenital neutropenia. Because of the important role of Hax1 in neutrophils we demonstrate here validation of two commercially available research antibodies directed against human Hax1 in the human myeloid leukemia cell line PLB-985 cells. We show that both the mouse anti-Hax1 monoclonal IgG directed against amino acids 10-148 of Hax1 and a rabbit anti-Hax1 polyclonal IgG antibody directed against full-length Hax1 reliably and consistently detect Hax1 during immunoblotting of three different PLB-985 cell densities. Using shRNA mediated Hax1 knockdown, we demonstrate the specificity of both Hax1 antibodies. In addition, our results suggest that the rabbit anti-Hax1 polyclonal antibody provides a stronger intensity in detecting Hax1 protein, with detection in as few as 0.1 x 10 6 cells in 6 total replicates we have performed.

Keywords

Hax1, neutrophil, PLB-985, tubulin

Revised Amendments from Version 1

This revision incorporates suggestions from the referees and includes all updated figures along with additional data sets 1 and 2. The following updates and revisions have been incorporated into the publication:

  1. All Western blots have been separated to clearly display the goat anti-rabbit 680 channel and the goat anti-mouse 800 channel. This was to further explain and demonstrate the source of background bands observed in the goat anti-rabbit 680 channel.
     
  2. The text was updated to clearly explain that these two antibodies are commercially available. In addition, the buffer compositions of the 6x Laemmli buffer and transfer buffer have been included.
     
  3. Figure 3 now contains quantification of the band intensities of the the mouse anti-Hax1 and rabbit anti-Hax1 antibodies from three independent replicates.
     
  4. Figure 4 includes quantification of the band intensities using the mouse anti-Hax1 and rabbit anti-Hax1 antibodies in the control shRNA and Hax1 shRNA cell lines to demonstrate that at the 1 x 10^6 cell density both antibodies exhibit similar knockdown levels. This demonstrates their specificity.
     
  5. Figure 5 now includes more controls to establish the origin of background bands observed in the goat anti-rabbit 680 blots. We tested rabbit and mouse pre-immune sera to determine if this could be the source of the background. We found that in fact we got more background with the sera. Using secondary antibodies only we show that there is no background observed with the goat anti-mouse 800 antibody but we see a characteristic background pattern using the goat anti-rabbit 680 antibody. Subsequent incubation of these secondary only blots with either the rabbit anti-Hax1 or mouse anti-Hax1 antibodies show the appearance of Hax1. These two combinations clearly demonstrate that the background bands are coming from the goat anti-rabbit secondary antibody.

See the authors' detailed response to the review by Mautusi Mitra
See the authors' detailed response to the review by Lawrence L. LeClaire III
See the authors' detailed response to the review by Andrew D. Chalmers

Introduction

HS1-associated protein X-1 (Hax1) is a 35 kDa protein consisting of 279 amino acids that is ubiquitously expressed1. Hax1 has been demonstrated to be a negative regulator of apoptosis in many immune cell types24. Furthermore, Hax1 has been shown to have additional roles in regulating cell motility and adhesion5,6, and is overexpressed in many types of cancer7. Patients with autosomal recessive mutations in the HAX1 gene have a form of severe congenital neutropenia called Kostmann syndrome. Severe congenital neutropenia is characterized by early recurrent bacterial infections and decreased neutrophil counts in the blood stream8.

Because of the recent increase in Hax1 investigations, it is important to identify reliable antibodies directed against Hax1. Using the human neutrophil model cell line PLB-985 cells, which can be terminally differentiated into neutrophil-like cells after treatment with DMSO, we demonstrate the applicability and selectivity of two commercially available antibodies against Hax1. A mouse Hax1 monoclonal antibody (BD Biosciences) that is routinely used in publications investigating Hax15,6,911 directed against Hax1 amino acids 10–148, and a rabbit polyclonal antibody (Proteintech Group, Inc.) directed against the full length Hax1 protein6.

Materials and methods

Reagent details

Details of all reagents used in the Western blotting procedures can be found in Table 1.

Table 1. Details of reagents used for immunoblotting.

ProcessReagentManufacturerCatalogue
Number
Concentration
6× Laemmli Protein
Loading Buffer
Tris-HCL
SDS
Glycerol
Bromophenol blue
DL-Dithiothreitol
Fisher Scientific
Fisher Scientific
Fisher Scientific
Sigma-Aldrich
Sigma-Aldrich
Tris base BP152
BP166-100
G33-1
B0126
D0632
375mM
9%
50%
0.03%
0.6M
Protein blotting0.45μm nitrocellulose pure
transfer membrane
Santa Cruz
Biotechnology
Sc-201705
SDS-PAGE Transfer
Buffer
1× Tris-Gylcine Electroblotting
buffer
Methanol
National Diagnostics

Fisher Scientific
EC-800

A412-4
1× (25mM Tris-HCL,
192mM glycine)
20% v/v
Wash Buffer, blocking
buffer, and Antibody
Diluent
Tween-Tris/Saline (T-TS)Fisher ScientificTris base BP152
NaCl S271
Tween-20 BP337
50mM Tris
150mM NaCl
1% Tween -20
BlockingBovine Serum Albumin, heat
shock fraction
Sigma-AldrichA96475% in T-TS
Pre-Immune Serum
Incubation (Figure 5A)
Rabbit pre-immune serum
Mouse pre-immune serum
Sigma-Aldrich
Sigma-Aldrich
R9133
M5905
1:1000
1:1000

Antibody details

Anti-tubulin (beta-) is a mouse monoclonal IgG1 [E7 was deposited to the DSHB by Klymkowsky, Michael (DSHB Hybridoma Product E7)] and was used as a loading control for all Western blots at a dilution of 1:1000 resulting in a final concentration of 45 ng/mL. Rabbit anti-Hax1 (Proteintech Group, Inc, Table 2) is a polyclonal antibody generated to full length Homo sapiens Hax1. The lot number used was 1, and a dilution of 1:1000 was used for all Western blots resulting in a final concentration of rabbit anti-Hax1 of 230 ng/mL. Mouse anti-Hax1 (BD Biosciences) is a mouse monoclonal IgG1 raised against Homo sapiens Hax1 amino acids 10–148. The lot number used was 3266979, and a dilution of 1:1000 was used for all Western blots resulting in a final concentration of 250 ng/mL. Goat anti-rabbit IgG IRDye 680LT and Goat anti-mouse IgG IRDye 800CW (Li-Cor Biosciences, Table 2) were used at a dilution of 1:40,000 (25 ng/mL).

Table 2. Details of Primary and Secondary Antibodies.

AntibodyManufacturerCatalogue
number
RRIDConcentration
used
Tubulin (beta-)Developmental
Studies Hybridoma Bank
E7-sRRID:AB_52849945 ng/mL
Hax1BD Biosciences610824RRID:AB_398143250 ng/mL
Hax1Proteintech Group, Inc.11266-1-APRRID:AB_2263720230 ng/mL
Goat anti-Rabbit
IgG IRDye 680LT
Li-Cor Biosciences926-32221RRID:AB_62184125 ng/mL
Goat anti-Mouse
IgG IRDye 800CW
Li-Cor Biosciences827-08364RRID:AB_1079385625 ng/mL

Cell culture

PLB-985 cells were maintained in RPMI 1640 (Mediatech, Inc.) supplemented with 10% fetal bovine serum, 60 μg/mL penicillin, and 100 μg/mL streptomycin (Mediatech, Inc.) at a concentration of 0.1–1 × 106 cells/mL. To differentiate PLB-985 cells into “neutrophil-like” cells 1.25% DMSO (Fisher Scientific) was added to 2 × 105 cells/mL for 6 days. Lentiviral Hax1 shRNA targets were purchased from Open Biosystems. Targets used; Hax1 shRNA (5'-ACAGACACTTCGGGACTCAAT-3') and control shRNA (5'-TGTCTCCGAACGTGTCACGTT-3'). HEK293-FT cells were grown to 70% confluency in a 10cm tissue culture dish for each lentiviral target and transfected using 6μg Hax1, 0.6μg vesicular stomatitis virus (VSV)-G, and 5.4μg cytomegalovirus (CMV) 8.9.1. 72 hour viral supernatant was collected and concentrated using Lenti-X concentrator (Clontech, Inc.) following the manufacturer’s instructions. 1 × 106 PLB-985 cells were infected with viral supernatant for 3 days in the presence of polybrene (4 μg/mL, Santa Cruz Biotechnology). Stable cell lines were generated with puromycin (1 μg/mL, Sigma Aldrich) selection.

Immunoblot analysis

  • Differentiated PLB-985 cells were counted and 0.1 × 106, 0.5 × 106, and 1 × 106 cells were pelleted by centrifugation.

  • Cells were lysed in Triton X-100 lysis buffer with protease inhibitors (25 mM HEPES, pH 7.5, 150 mM NaCl2, 1% TX-100, 10 mM MgCl2, 1 mM EDTA, 10% glycerol, 1 μg/mL pepstatin A, 2 μg/mL aprotinin, 1 μg/mL leupeptin) on ice for 10 minutes and clarified by centrifugation.

  • Cellular lysate was then removed and added to 6× Laemmli sample buffer, boiled at 90°C for 5 minutes, and run on 10% SDS-PAGE gels.

  • Proteins were then transferred to 0.45μm nitrocellulose membranes (Santa Cruz Biotechnology) at 400mA for 1 hour at 4°C.

  • Following transfer, the membrane was blocked in 5% BSA in 1× T-TS for 1 hour at room temperature with gentle rocking.

  • Membranes were then probed with mouse anti-tubulin [(beta-) (45 ng/mL)], and either mouse anti-Hax1 (BD Biosciences, 250 ng/mL) or rabbit anti-Hax1 (Proteintech Group, Inc., 230 ng/mL) at room temperature for 1 hour.

  • After primary antibody incubation the membranes were washed 3 × 5 minutes with 1× Tris-HCL/NaCl saline buffer (1× T-TS), see Table 1.

  • The membranes were incubated with goat anti-rabbit IgG IRDye 680LT and goat anti-mouse IgG IRDye 800CW (Li-Cor Biosciences, 25 ng/mL) at room temperature for 1 hour.

  • After secondary antibody incubation the membranes were washed 3 × 5 minutes with 1× T-TS.

  • Blots were imaged with an infrared imaging system (Odysssey Fc; Li-Cor Biosciences) using a 2-minute exposure time.

Results

To determine the reproducibility and sensitivity of the mouse and rabbit anti-Hax1 antibodies on the PLB-985 cells, we performed Western blot analysis using three separate cell densities, 0.1 × 106, 0.5 × 106, and 1 × 106 cells. In our research using the PLB-985 cell system, we routinely use 1 × 106 – 10 × 106 cells in a Western blot. Using beta-tubulin as a loading control our Western blots illustrate an increasing protein concentration in the three samples as would be expected with increasing cell densities. We found that the mouse anti-Hax1 antibody (BD Biosciences) is visible as low as 0.5 × 106 cells, binding to a protein band at the expected Hax1 size with a relative mobility of 35 kDa (Figure 1). In six different experiments (Figure 1 and Figure 4) we found inconsistency in protein detection with the Ms anti-Hax1 antibody. In all blots Hax1 was visible, however with varying degrees of intensity. Conversely, when the rabbit anti-Hax1 antibody (Proteintech Group, Inc.) was used, the antibody gave consistent and robust detection (Figure 2 and Figure 4). In some cases, Hax1 can be detected in as low as 0.1 × 106 cells using the rabbit anti-Hax1 antibody (Figure 2C). We do not believe the difference between the two antibodies is due to variations in the cell extract or imaging software because when the same cell extract is immunoblotted on two different blots and scanned simultaneously the difference in sensitivity can be observed (Figure 3A). Using the Odyssey imaging system (Li-Cor Biosciences) to measure the intensity of each band, we calculated the intensity ratio of Hax1 relative to the tubulin loading control from three independent blots for each antibody (Figure 3B). In both blots the levels of tubulin are similar, however it is evident that the rabbit anti-Hax1 antibody exhibits a stronger signal compared to the mouse monoclonal antibody. Nevertheless, it should be noted that both antibodies reliably detect Hax1 in differentiated PLB-985 cells.

To demonstrate the specificity of both Hax1 antibodies we generated stably-expressing control shRNA and Hax1 shRNA PLB-985 cells (Figure 4). As described previously using the mouse anti-Hax1 antibody the control shRNA cells show inconsistent staining intensity, however in these samples the mouse anti-Hax1 antibody is more robust than in the wild-type PLB-985 cells. Both the mouse anti-Hax1 and rabbit anti-Hax1 antibodies show reduced detection in the Hax1-deficient PLB-985 cells. Quantification of the level of Hax1 knockdown is consistent using the two antibodies at 1 x 106 cells. This demonstrates that the antibodies are highly specific for Hax1. In many of the experiments we observed additional background bands in the rabbit 680nm channel. To determine the source of these background bands rabbit and mouse pre-immune serum were tested (Figure 5A). Our results show a unique background pattern using the pre-immune serum that we do not observe on the Hax1 blots. We next performed a Western blot on cells using only the rabbit and mouse secondary antibodies (Figure 5B). The mouse channel does not display any significant background, however the rabbit secondary antibodies shows a background staining that we observe in the previous blots as well. These blots were then subsequently probed with the rabbit and mouse Hax1 antibodies (Figure 5C). Comparison of the secondary only blot before and after Hax1 antibody incubation demonstrates that the Hax1 antibodies are highly specific and the background we are observing can be attributed to the goat anti-rabbit IgG secondary antibody.

864d5e0d-6dae-4513-b1d8-a778857c632d_figure1.gif

Figure 1. Detection of Hax1 in differentiated PLB-985 cells using a mouse anti-Hax1 antibody.

Western blot analysis of differentiated PLB-985 cell lysates from 0.1 × 106, 0.5 × 106, and 1 × 106 cells from three independent replicates. Mouse anti-tubulin (beta-) is used as a loading control and can be seen present at a relative mobility of 55 kDa in the goat anti-mouse 800 channel. Mouse anti-Hax1 detects a band with a relative mobility of 35 kDa as predicted. Hax1 can be detected in densities of 0.5 × 106 and 1 × 106 cells.

864d5e0d-6dae-4513-b1d8-a778857c632d_figure2.gif

Figure 2. Detection of Hax1 in differentiated PLB-985 cells using a rabbit anti-Hax1 antibody.

Western blot analysis of differentiated PLB-985 cell lysates from 0.1 × 106, 0.5 × 106, and 1 × 106 cells from three independent replicates. Mouse anti-tubulin (beta-) is used as a loading control and can be seen present at a relative mobility of 55 kDa. Rabbit anti-Hax1 detects a band at a relative mobility of 35 kDa as predicted. Hax1 can be detected in densities as low as 0.1 × 106 cells (C).

864d5e0d-6dae-4513-b1d8-a778857c632d_figure3.gif

Figure 3. Comparison of mouse and rabbit anti-Hax1 antibodies in differentiated PLB-985 cells.

(A) Western blot analysis of differentiated PLB-985 cell lysates from 0.1 × 106, 0.5 × 106, and 1 × 106 cells comparing mouse and rabbit anti-Hax1 antibodies. Lysates from the same cell extractions were run on a single SDS-PAGE gel and blotted onto a single nitrocellulose membrane. After transfer, the membrane was divided and probed with either mouse anti-Hax1 or rabbit anti-Hax1. The membranes were imaged simultaneously. (B) Quantification of the ratios of Hax1 and tubulin band intensities from three independent blots were measured and plotted. Error bars indicate standard deviation.

864d5e0d-6dae-4513-b1d8-a778857c632d_figure4.gif

Figure 4. Detection of Hax1 in Control shRNA and Hax1 shRNA expressing differentiated PLB-985 cells using mouse and rabbit anti-Hax1 antibodies.

(AC) Western blot analysis of differentiated PLB-985 cell lysates from 0.1 × 106, 0.5 × 106, and 1 × 106 cells expressing either control shRNA or Hax1 shRNA from three independent replicates. Mouse anti-tubulin (beta-) is used as a loading control and can be seen present at a relative mobility of 55 kDa. Both mouse and rabbit anti-Hax1 detects a band at a relative mobility of 35 kDa as predicted. (D) Quantification of the band intensities of tubulin and Hax1 relative to control shRNA from three independent Western blots. Error bars indicate standard error of the mean. p values were calculated using paired t-test to assess significance relative to control shRNA.

864d5e0d-6dae-4513-b1d8-a778857c632d_figure5.gif

Figure 5. Goat anti-Rabbit IgG secondary antibody only background detection of differentiated PLB-985 cell lysates.

(A) Western blot analysis using rabbit and mouse pre-immune serum from 0.1 × 106, 0.5 × 106, and 1 × 106 differentiated PLB-985, control shRNA, and Hax1 shRNA cells. (B) Western blot analysis using goat anti-rabbit IgG 680LT only on cell lysates from 0.1 × 106, 0.5 × 106, and 1 × 106 differentiated PLB-985, control shRNA and Hax1 shRNA expressing PLB-985 cells. Two predominant background bands can be observed at a relative mobility of 60 and 70 kDa, and one band around 30 kDa. These background bands can also be seen in Figure 1, Figure 2, and Figure 4. (C) Subsequent incubation with rabbit and mouse anti-Hax1 from Western blots shown in B demonstrate the appearance of the Hax1 band at the predicted 35 kDa size.

Dataset 1.Raw data for Figure 3 quantification.
Comparison of mouse and rabbit anti-Hax1 antibody band intensities in differentiated PLB-985 cells. Quantification of the band intensities from three independent Western blots was measured and the ratios of Hax1 to tubulin were plotted.
Dataset 2.Raw data for Figure 4 quantification.
Detection and quantification of Hax1 in control shRNA and Hax1 shRNA expressing PLB-985 cells. Quantification of the band intensities was measured and the ratios of Hax1 to tubulin were plotted relative to the control shRNA ratios for each cell density assayed. An average, standard deviation, and standard error of the mean were calculated for each cell density and each antibody used from three independent replicates.

Conclusion

Here we show validation and comparison results of two commercially available antibodies generated against HS1-associated protein X-1 (Hax1), an anti-apoptotic protein that has a multi-factorial role in regulating cell proliferation and differentiation, cell motility, and cancer. Homozygous loss-of-function of Hax1 results in severe congenital neutropenia, a life threatening loss of circulating neutrophils in the blood stream. Studying the function of Hax1 in primary neutrophils and the neutrophil model cell line PLB-985 will help elucidate the disease pathogenesis of neutropenia syndromes. We demonstrate that mouse anti-Hax1 (BD Biosciences) and rabbit anti-Hax1 (Proteintech Group, Inc.) are both specific for Hax1. Furthermore we show that as little as 0.5 × 106 differentiated PLB-985 cells can be used to reliably detect Hax1 expression with both of the antibodies. We have evidence that the rabbit anti-Hax1 (Proteintech Group Inc.) results in a more robust and consistent detection of Hax1, likely due to the polyclonal nature of the antibody. Finally, lentiviral knockdown of endogenous Hax1 expression results in loss of Hax1 detection by both mouse anti-Hax1 and rabbit anti-Hax1 demonstrating the specificity of each antibody. In our quantification of Hax1 knockdown we observed variation when the cell densities were low, with 1 × 106 cells giving us the most reliable quantification. In our experiments we observed background bands that we attributed to the goat anti-rabbit 680nm secondary antibody. Therefore we are confident that these antibodies are very specific.

In conclusion we recommend the use of either mouse or rabbit anti-Hax1 antibodies shown here for studies using the PLB-985 cells as a neutrophil model cell line. It is our conclusion that a minimum cell density of 0.5 × 106 neutrophils should be used as a starting point for immunoblotting of Hax1, with greater than or equal to 1 × 106 cells being optimal.

Data availability

F1000Research: Dataset 1. Raw data for Figure 3 quantification., 10.5256/f1000research.6516.d9934312

F1000Research: Dataset 2. Raw data for Figure 4 quantification., 10.5256/f1000research.6516.d9934413

Comments on this article Comments (0)

Version 2
VERSION 2 PUBLISHED 10 Jun 2015
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Cavnar P and Inman K. Immunoblotting validation of research antibodies generated against HS1-associated protein X-1 in the human neutrophil model cell line PLB-985. [version 2; peer review: 3 approved]. F1000Research 2015, 4:148 (https://doi.org/10.12688/f1000research.6516.2)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 2
VERSION 2
PUBLISHED 10 Aug 2015
Revised
Views
10
Cite
Reviewer Report 18 Aug 2015
Mautusi Mitra, Department of Biology, University of West Georgia, Carrollton, GA, USA 
Approved
VIEWS 10
The authors have taken into consideration the reviewers' ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Mitra M. Reviewer Report For: Immunoblotting validation of research antibodies generated against HS1-associated protein X-1 in the human neutrophil model cell line PLB-985. [version 2; peer review: 3 approved]. F1000Research 2015, 4:148 (https://doi.org/10.5256/f1000research.7428.r9934)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Views
7
Cite
Reviewer Report 13 Aug 2015
Andrew D. Chalmers, Department of Biology and Biochemistry, University of Bath, Bath, UK 
Approved
VIEWS 7
All my concerns ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Chalmers AD. Reviewer Report For: Immunoblotting validation of research antibodies generated against HS1-associated protein X-1 in the human neutrophil model cell line PLB-985. [version 2; peer review: 3 approved]. F1000Research 2015, 4:148 (https://doi.org/10.5256/f1000research.7428.r9936)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Version 1
VERSION 1
PUBLISHED 10 Jun 2015
Views
16
Cite
Reviewer Report 08 Jul 2015
Lawrence L. LeClaire III, Department of Biochemistry and Molecular Biology, University of South Alabama, Mobile, AL, USA 
Approved
VIEWS 16
Kristina and Cavnar present data to validate two commercial antibodies for HSA-associated protein X-1 in a human neutrophil cell line. The authors describe the conditions for the experiments as well as provide sufficient information/protocols for reader about the conditions used ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
LeClaire III LL. Reviewer Report For: Immunoblotting validation of research antibodies generated against HS1-associated protein X-1 in the human neutrophil model cell line PLB-985. [version 2; peer review: 3 approved]. F1000Research 2015, 4:148 (https://doi.org/10.5256/f1000research.6992.r9247)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 10 Aug 2015
    Peter Cavnar, Department of Biology, University of West Florida, Pensacola, 32514, USA
    10 Aug 2015
    Author Response
    Thank you for your kind review. I have revised and submitted a new version of this manuscript. Per your questions I will address each one:
    1. I have included the commercial availability
    ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 10 Aug 2015
    Peter Cavnar, Department of Biology, University of West Florida, Pensacola, 32514, USA
    10 Aug 2015
    Author Response
    Thank you for your kind review. I have revised and submitted a new version of this manuscript. Per your questions I will address each one:
    1. I have included the commercial availability
    ... Continue reading
Views
17
Cite
Reviewer Report 06 Jul 2015
Mautusi Mitra, Department of Biology, University of West Georgia, Carrollton, GA, USA 
Approved
VIEWS 17
The paper titled “"Immunoblotting validation of research antibodies generated against HS1-associated protein X-1 in the human neutrophil model cell line PLB-985." by Kristina and Cavnar focuses on the validation of two commercial antibodies generated against the human Hax1 protein. The ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Mitra M. Reviewer Report For: Immunoblotting validation of research antibodies generated against HS1-associated protein X-1 in the human neutrophil model cell line PLB-985. [version 2; peer review: 3 approved]. F1000Research 2015, 4:148 (https://doi.org/10.5256/f1000research.6992.r9249)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 10 Aug 2015
    Peter Cavnar, Department of Biology, University of West Florida, Pensacola, 32514, USA
    10 Aug 2015
    Author Response
    Thank you for your kind review of our manuscript. Below I have addressed your comments:
    1. We have clarified in the abstract, introduction, and discussion that these antibodies are commercially available.
       
    2. We have
    ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 10 Aug 2015
    Peter Cavnar, Department of Biology, University of West Florida, Pensacola, 32514, USA
    10 Aug 2015
    Author Response
    Thank you for your kind review of our manuscript. Below I have addressed your comments:
    1. We have clarified in the abstract, introduction, and discussion that these antibodies are commercially available.
       
    2. We have
    ... Continue reading
Views
22
Cite
Reviewer Report 18 Jun 2015
Andrew D. Chalmers, Department of Biology and Biochemistry, University of Bath, Bath, UK 
Approved
VIEWS 22
The work presented by Kristina and Cavnar presents data validating two commercial antibodies raised against Hax1. Their experimental approach is well explained and there is a good description of the methods and reagents used. The data is also convincing and ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Chalmers AD. Reviewer Report For: Immunoblotting validation of research antibodies generated against HS1-associated protein X-1 in the human neutrophil model cell line PLB-985. [version 2; peer review: 3 approved]. F1000Research 2015, 4:148 (https://doi.org/10.5256/f1000research.6992.r8986)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 10 Aug 2015
    Peter Cavnar, Department of Biology, University of West Florida, Pensacola, 32514, USA
    10 Aug 2015
    Author Response
    Thank you for the kind review of our manuscript. We have addressed your comments below:
    1. Commercial availability of the antibodies has now been included in the abstract, introduction, and discussion.
       
    2. We have
    ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 10 Aug 2015
    Peter Cavnar, Department of Biology, University of West Florida, Pensacola, 32514, USA
    10 Aug 2015
    Author Response
    Thank you for the kind review of our manuscript. We have addressed your comments below:
    1. Commercial availability of the antibodies has now been included in the abstract, introduction, and discussion.
       
    2. We have
    ... Continue reading

Comments on this article Comments (0)

Version 2
VERSION 2 PUBLISHED 10 Jun 2015
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.